EBV infection determines the immune hallmarks of plasmablastic lymphoma
Despite recent therapeutic progress, plasmablastic lymphoma (PBL), a distinct entity of high grade B cell lymphoma, is still an aggressive lymphoma with adverse prognosis. PBL commonly occurs in patients with HIV infection and PBL cells frequently express Epstein Barr virus (EBV) genome with type I...
Main Authors: | Pauline Gravelle, Sarah Péricart, Marie Tosolini, Bettina Fabiani, Paul Coppo, Nadia Amara, Alexandra Traverse-Gléhen, Nathalie Van Acker, Pierre Brousset, Jean-Jacques Fournie, Camille Laurent |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-10-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2018.1486950 |
Similar Items
-
Case Report: Successful Management of a Refractory Plasmablastic Lymphoma Patient With Tislelizumab and Lenalidomide
by: Lili Cheng, et al.
Published: (2021-07-01) -
The molecular profile of oral plasmablastic lymphomas in a South African population sample
by: Boy, Sonja Catharina
Published: (2013) -
Primary central nervous system plasmablastic lymphoma presenting in human immunodeficiency virus-negative but Epstein-Barr virus-positive patient: A case report
by: Zhang Li, et al.
Published: (2012-05-01) -
EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 2)
by: Magda Zanelli, et al.
Published: (2021-09-01) -
Determination of the association between Epstein-Barr virus (EBV) infection and Multiple sclerosis (MS) disease
by: Reza Taherkhani, et al.
Published: (2014-10-01)